Interest in psychedelic drugs has grown in recent years alongside research into their potential as tools to treat mental health. That’s especially true in Colorado where, in 2022, voters approved the establishment of a regulated industry around psychedelic-assisted therapy . While the bulk of formal studies focus on the effects of ingesting large doses, the wellness industry has popularized a concept called microdosing , which involves taking small amounts of drugs like psilocybin or LSD as a supplement.
This idea is to enhance physical and mental well-being without inducing a full psychedelic experience or trip. Most psychedelic drugs are still illegal in the eyes of the federal government, however, so even though microdosing has inched its way into the mainstream lexicon, it simultaneously remains part of an underground culture. A Colorado company is working to create a microdosing drug for approval by the U.
S. Food and Drug Administration, but until that happens doctors cannot prescribe microdoses to patients. And there’s another catch: To be approved as a medicine, microdosing needs to be proven to work.
Right now, scientists don’t agree on if it does. Microdosing hasn’t been studied extensively, but the various methods used to do so often produce varying results. Much of the available data comes from observational studies in which users share anecdotal information about their experiences.
Reports are usually overwhelmingly positive with people citing benefits fro.